Pancreatic Disease Institute, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, Wuhan City, China.
Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.
Gene Ther. 2015 Sep;22(9):729-38. doi: 10.1038/gt.2015.39. Epub 2015 Apr 28.
Recent researches demonstrate that microRNAs (miRNAs) are deregulated in numerous cancers and involved in tumorigenesis, whereas their influences on pancreatic cancer (PC) still need further elucidation. The present research revealed that miR-494 was significantly decreased in PC cell lines and tissues. Functional study showed that overexpressed miR-494 could remarkably inhibit proliferation of PC cells both in vitro and in vivo, which was due to induction of apoptosis, G1-phase arrest and senescence. Moreover, upregulated miR-494 significantly prohibited invasion of PC cells. Meanwhile, both c-Myc and SIRT1 was identified as targets of miR-494 through dual luciferase assay and further confirmed by the reverse correlation between miR-494 and c-Myc/SIRT1 in PC samples. Furthermore, co-transfection with c-Myc-RNAi and SIRT1-RNAi synergistically reduced c-Myc and SIRT1 expression, and inhibited proliferation of PC, which simulated the effects of miR-494 overexpression. On the contrary, co-overexpression of c-Myc and SIRT1 effectively rescued inhibition of overexpressed miR-494 on PC cells. The clinical characteristics further revealed that low miR-494 correlated with larger tumor size, late tumor node metastasis stage, lymphatic invasion, distant metastasis and poor prognosis. In conclusion, the present study indicated that miR-494 might serve as predictor and inhibitor in PC by directy downregulating the loop of c-Myc and SIRT1.
最近的研究表明,微小 RNA(miRNAs)在许多癌症中失调,参与肿瘤发生,而它们对胰腺癌(PC)的影响仍需要进一步阐明。本研究表明,miR-494 在 PC 细胞系和组织中显著下调。功能研究表明,过表达 miR-494 可显著抑制 PC 细胞的体外和体内增殖,这是由于诱导细胞凋亡、G1 期阻滞和衰老。此外,上调 miR-494 可显著抑制 PC 细胞的侵袭。同时,通过双荧光素酶报告实验鉴定出 c-Myc 和 SIRT1 是 miR-494 的靶标,并通过 miR-494 与 PC 样本中 c-Myc/SIRT1 的反向相关性进一步证实。此外,c-Myc-RNAi 和 SIRT1-RNAi 的共转染协同降低了 c-Myc 和 SIRT1 的表达,并抑制了 PC 的增殖,模拟了 miR-494 过表达的作用。相反,c-Myc 和 SIRT1 的共过表达有效挽救了过表达 miR-494 对 PC 细胞的抑制作用。临床特征进一步表明,低 miR-494 与更大的肿瘤大小、晚期肿瘤淋巴结转移分期、淋巴浸润、远处转移和不良预后相关。总之,本研究表明,miR-494 可能通过直接下调 c-Myc 和 SIRT1 的环,作为 PC 的预测因子和抑制剂。